RT @swethaann23: Avacopan (C5a inhibitor) is a new promising therapy for ANCA vasculitis. US FDA approved in Oct 2021 #A
Tweet Content
Avacopan (C5a inhibitor) is a new promising therapy for ANCA vasculitis. US FDA approved in Oct 2021
#ACR21 @rheumnow https://t.co/tWvKzHOT5V
Show on Archive Page
On
Display in Search Results
On
PDQ
Off